These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 31759728)

  • 21. Synthesis and biological evaluation of ferrocenylquinoline as a potential antileishmanial agent.
    Yousuf M; Mukherjee D; Pal A; Dey S; Mandal S; Pal C; Adhikari S
    ChemMedChem; 2015 Mar; 10(3):546-54. PubMed ID: 25619822
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antileishmanial 2-substituted quinolines: in vitro behaviour towards biological components.
    Desrivot J; Herrenknecht C; Ponchel G; Garbi N; Prina E; Fournet A; Bories C; Figadère B; Hocquemiller R; Loiseau PM
    Biomed Pharmacother; 2007 Aug; 61(7):441-50. PubMed ID: 17459651
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Syntheses of new substituted triazino tetrahydroisoquinolines and beta-carbolines as novel antileishmanial agents.
    Kumar A; Katiyar SB; Gupta S; Chauhan PM
    Eur J Med Chem; 2006 Jan; 41(1):106-13. PubMed ID: 16356594
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Synthesis of novel guttiferone A derivatives: in-vitro evaluation toward Plasmodium falciparum, Trypanosoma brucei and Leishmania donovani.
    Fromentin Y; Gaboriaud-Kolar N; Lenta BN; Wansi JD; Buisson D; Mouray E; Grellier P; Loiseau PM; Lallemand MC; Michel S
    Eur J Med Chem; 2013 Jul; 65():284-94. PubMed ID: 23727538
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Design, synthesis and evaluation of 2,4-diaminoquinazolines as inhibitors of trypanosomal and leishmanial dihydrofolate reductase.
    Khabnadideh S; Pez D; Musso A; Brun R; Pérez LM; González-Pacanowska D; Gilbert IH
    Bioorg Med Chem; 2005 Apr; 13(7):2637-49. PubMed ID: 15755663
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Synthesis and biological evaluation of polyhydroxylated oxindole derivatives as potential antileishmanial agent.
    Yousuf M; Mukherjee D; Dey S; Chatterjee S; Pal A; Sarkar B; Pal C; Adhikari S
    Bioorg Med Chem Lett; 2018 Apr; 28(6):1056-1062. PubMed ID: 29478704
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Anti-Leishmanial and Cytotoxic Activities of a Series of Maleimides: Synthesis, Biological Evaluation and Structure-Activity Relationship.
    Fan Y; Lu Y; Chen X; Tekwani B; Li XC; Shen Y
    Molecules; 2018 Nov; 23(11):. PubMed ID: 30400596
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Design and synthesis of novel substituted quinazoline derivatives as antileishmanial agents.
    Agarwal KC; Sharma V; Shakya N; Gupta S
    Bioorg Med Chem Lett; 2009 Sep; 19(18):5474-7. PubMed ID: 19692240
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Synthesis, Biological Evaluation, Structure-Activity Relationship, and Mechanism of Action Studies of Quinoline-Metronidazole Derivatives Against Experimental Visceral Leishmaniasis.
    Upadhyay A; Chandrakar P; Gupta S; Parmar N; Singh SK; Rashid M; Kushwaha P; Wahajuddin M; Sashidhara KV; Kar S
    J Med Chem; 2019 Jun; 62(11):5655-5671. PubMed ID: 31124675
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dual inhibition of DNA topoisomerases of Leishmania donovani by novel indolyl quinolines.
    Ray S; Sadhukhan PK; Mandal NB; Mahato SB; Majumder HK
    Biochem Biophys Res Commun; 1997 Jan; 230(1):171-5. PubMed ID: 9020039
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Structure based medicinal chemistry-driven strategy to design substituted dihydropyrimidines as potential antileishmanial agents.
    Rashid U; Sultana R; Shaheen N; Hassan SF; Yaqoob F; Ahmad MJ; Iftikhar F; Sultana N; Asghar S; Yasinzai M; Ansari FL; Qureshi NA
    Eur J Med Chem; 2016 Jun; 115():230-44. PubMed ID: 27017551
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Synthesis and evaluation of 2-pyridyl pyrimidines with in vitro antiplasmodial and antileishmanial activity.
    Musonda CC; Whitlock GA; Witty MJ; Brun R; Kaiser M
    Bioorg Med Chem Lett; 2009 Jan; 19(2):401-5. PubMed ID: 19091562
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Synthesis and antiprotozoal activity of some new synthetic substituted quinoxalines.
    Hui X; Desrivot J; Bories C; Loiseau PM; Franck X; Hocquemiller R; Figadère B
    Bioorg Med Chem Lett; 2006 Feb; 16(4):815-20. PubMed ID: 16309903
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Quinoxaline derivatives as potential antitrypanosomal and antileishmanial agents.
    Cogo J; Cantizani J; Cotillo I; Sangi DP; Corrêa AG; Ueda-Nakamura T; Filho BPD; Martín JJ; Nakamura CV
    Bioorg Med Chem; 2018 Aug; 26(14):4065-4072. PubMed ID: 30100019
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antileishmanial evaluation of clubbed bis(indolyl)-pyridine derivatives: One-pot synthesis, in vitro biological evaluations and in silico ADME prediction.
    Khan FA; Zaheer Z; Sangshetti JN; Patil RH; Farooqui M
    Bioorg Med Chem Lett; 2017 Feb; 27(3):567-573. PubMed ID: 28003139
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Diastereoselective synthesis of substituted hexahydrobenzo[de]isochromanes and evaluation of their antileishmanial activity.
    Saikia AK; Sultana S; Devi NR; Deka MJ; Tiwari K; Dubey VK
    Org Biomol Chem; 2016 Jan; 14(3):970-9. PubMed ID: 26625982
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Structural and functional highlights of methionine aminopeptidase 2 from Leishmania donovani.
    Bhat SY; Dey A; Qureshi IA
    Int J Biol Macromol; 2018 Aug; 115():940-954. PubMed ID: 29680505
    [TBL] [Abstract][Full Text] [Related]  

  • 38. New antiprotozoal agents: their synthesis and biological evaluations.
    Upadhayaya RS; Dixit SS; Földesi A; Chattopadhyaya J
    Bioorg Med Chem Lett; 2013 May; 23(9):2750-8. PubMed ID: 23518280
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Design, Synthesis and Antileishmanial Activity of Naphthotriazolyl-4- Oxoquinolines.
    Oliveira VG; Dos Santos Faiões V; Gonçalves GBR; Lima MFO; Boechat FCS; Cunha AC; de Andrade-Neto VV; de C da Silva F; Torres-Santos EC; de Souza MCBV
    Curr Top Med Chem; 2018; 18(17):1454-1464. PubMed ID: 30277154
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Eugenol derived immunomodulatory molecules against visceral leishmaniasis.
    Charan Raja MR; Velappan AB; Chellappan D; Debnath J; Kar Mahapatra S
    Eur J Med Chem; 2017 Oct; 139():503-518. PubMed ID: 28826085
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.